CONMED CORP (CNMD) is a publicly traded company in the Unknown sector. Across all available filings, 33 corporate insiders have executed 1013 transactions totaling $96.2M, demonstrating a bearish sentiment with -$93.4M in net insider flow. The most recent transaction on Feb 24, 2026 involved a transaction of 152 shares valued at $0.
No significant insider buying has been recorded for CNMD in the recent period.
No significant insider selling has been recorded for CNMD in the recent period.
Based on recent SEC filings, insider sentiment for CNMD is bearish with an Insider Alignment Score of 1/100 and a net flow of -$93.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CONMED CORP (CNMD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 33 insiders are actively trading CNMD stock, having executed 1013 transactions in the past 90 days. The most active insider is Curt R. Hartman (Executive), who has made 42 transactions totaling $44.3M.
Get notified when executives and directors at CNMD file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Kaye Mark | Executive | Option Exercise | 152 | $N/A | $0 | |
| Feb 24, 2026 | Kaye Mark | Executive | Option Exercise | 152 | $N/A | $0 | |
| Nov 21, 2025 | Glaze Richard | Executive | Sale | 257 | $41.21 | $10.6K | |
| Nov 20, 2025 | Glaze Richard | Executive | Option Exercise | 375 | $N/A | $0 | |
| Nov 20, 2025 | Glaze Richard | Executive | Payment | 118 | $40.63 | $4.8K | |
| Nov 6, 2025 | W. Garner Todd | Executive | Sale | 3,500 | $43.00 | $150.5K | |
| Nov 4, 2025 | K. Foust Hollie | Executive | Payment | 1,114 | $45.71 | $50.9K | |
| Nov 4, 2025 | K. Foust Hollie | Executive | Option Exercise | 4,000 | $N/A | $0 | |
| Oct 31, 2025 | W. Garner Todd | Executive | Payment | 2,164 | $44.00 | $95.2K | |
| Oct 31, 2025 | W. Garner Todd | Executive | Option Exercise | 7,500 | $N/A | $0 | |
| Sep 12, 2025 | Farkas Charles | Executive | Sale | 897 | $53.51 | $48.0K | |
| Sep 12, 2025 | Farkas Charles | Executive | Sale | 1,103 | $53.54 | $59.1K | |
| Aug 7, 2025 | W. Garner Todd | Executive | Sale | 598 | $52.45 | $31.4K | |
| Sep 5, 2024 | Farkas Charles | Executive | Option Exercise | 1,000 | $39.64 | $39.6K | |
| Sep 5, 2024 | Farkas Charles | Executive | Payment | 534 | $74.31 | $39.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 244 | $94.8M | 43.4% |
Payment(F) | 220 | $60.8M | 27.8% |
Exercise(M) | 415 | $60.0M | 27.5% |
Purchase(P) | 18 | $1.4M | 0.6% |
Award(A) | 71 | $745.8K | 0.3% |
Disposition(D) | 2 | $532.3K | 0.2% |
Other(J) | 15 | $188.6K | 0.1% |
Small Acquisition(L) | 3 | $348 | 0.0% |
Gift(G) | 25 | $0 | 0.0% |
Insider selling pressure at CONMED CORP has increased, with 33 insiders executing 1013 transactions across all time. Total sales of $94.8M significantly outpace purchases of $1.4M, resulting in a net outflow of $93.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.